Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21275961 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease
Condition: Hemoglobin SC Disease
Interventions: Drug: Hydroxyurea;   Drug: Magnesium Pidolate;   Other: Placebo Pills and Placebo Liquid

Indicates status has not been verified in more than two years